R
Ralph B. D'Agostino
Researcher at Wake Forest University
Publications - 1336
Citations - 250792
Ralph B. D'Agostino is an academic researcher from Wake Forest University. The author has contributed to research in topics: Framingham Heart Study & Framingham Risk Score. The author has an hindex of 226, co-authored 1287 publications receiving 229636 citations. Previous affiliations of Ralph B. D'Agostino include VA Boston Healthcare System & University of Illinois at Urbana–Champaign.
Papers
More filters
Journal ArticleDOI
A Class of Simple Linear Estimators of the Standard Deviation of the Normal Distribution
TL;DR: In this article, a class of simple linear estimators of the standard deviation of the normal distribution is considered, based on the differences between the sums of the observations in the tails of the ordered sample.
Journal ArticleDOI
Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs
Sengwee Toh,Jerry Avorn,Ralph B. D'Agostino,Jerry H. Gurwitz,Bruce M. Psaty,Bruce M. Psaty,Kenneth J. Rothman,Kenneth J. Rothman,Kenneth J. Rothman,Kenneth G. Saag,Miriam C. J. M. Sturkenboom,Jan P. Vandenbroucke,Almut G. Winterstein,Brian L. Strom +13 more
TL;DR: The FDA convened a committee to assess the implications of rapid assessments of dabigatran and bleeding risk and of olmesartan and celiac disease risk and how this general framework may apply to two completed rapid assessments.
Journal ArticleDOI
Estimating Lifetime Risk of Developing High Serum Total Cholesterol: Adjustment for Baseline Prevalence and Single-Occasion Measurements
TL;DR: To correctly quantify the long-term risk of developing high serum total cholesterol (> or =240 mg/dl or use of lipid-lowering medication), the authors propose a key modification of the lifetime risk statistic: adjustment for baseline prevalence.
Journal ArticleDOI
Objective performance goals of safety and blood pressure efficacy for clinical trials of renal artery bare metal stents in hypertensive patients with atherosclerotic renal artery stenosis.
Krishna J. Rocha-Singh,Victor Novack,Michael J. Pencina,Ralph B. D'Agostino,Gary M. Ansel,Kenneth Rosenfield,Michael R. Jaff +6 more
TL;DR: The co‐primary endpoints of 9 month reduction in blood pressure and in‐stent restenosis are proposed and will be analyzed as a continuous variable and compared to this performance goal.
Journal ArticleDOI
Radiographic complete response on post treatment CT imaging eliminates the need for adjuvant neck dissection after treatment for node positive head and neck cancer.
Kathryn M. Greven,Daniel W. Williams,J. Dale Browne,W. Fred Mcguirt,Douglas R. White,Ralph B. D'Agostino +5 more
TL;DR: There was no suggestion that neck dissection improved outcome for patients with rCR on posttreatment imaging 4 to 6 weeks after radiation.